329 related articles for article (PubMed ID: 37357527)
1. Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications.
Bowen DR; Pathak S; Nadar RM; Parise RD; Ramesh S; Govindarajulu M; Moore A; Ren J; Moore T; Dhanasekaran M
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(8):1153-1167. PubMed ID: 37357527
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities.
Alam MS; Czajkowsky DM
Cytokine Growth Factor Rev; 2022 Feb; 63():44-57. PubMed ID: 34836751
[TBL] [Abstract][Full Text] [Related]
5. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
[TBL] [Abstract][Full Text] [Related]
6. Neuropathies and neurological dysfunction induced by coronaviruses.
Gholami M; Safari S; Ulloa L; Motaghinejad M
J Neurovirol; 2021 Jun; 27(3):380-396. PubMed ID: 33983506
[TBL] [Abstract][Full Text] [Related]
7. How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection.
Kiełbowski K; Herian M; Pawlik A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742820
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
[TBL] [Abstract][Full Text] [Related]
9. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.
Aghagoli G; Gallo Marin B; Katchur NJ; Chaves-Sell F; Asaad WF; Murphy SA
Neurocrit Care; 2021 Jun; 34(3):1062-1071. PubMed ID: 32661794
[TBL] [Abstract][Full Text] [Related]
10. Neurological complications of COVID-19.
Dai X; Cao X; Jiang Q; Wu B; Lou T; Shao Y; Hu Y; Lan Q
QJM; 2023 Mar; 116(3):161-180. PubMed ID: 36484692
[TBL] [Abstract][Full Text] [Related]
11. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
12. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N
Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025
[TBL] [Abstract][Full Text] [Related]
13. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
14. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
15. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
16. Neuro-COVID-19: an insidious virus in action.
Bratosiewicz-Wąsik J
Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
[TBL] [Abstract][Full Text] [Related]
17. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
18. Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes?
Paul AK; Hossain MK; Mahboob T; Nissapatorn V; Wilairatana P; Jahan R; Jannat K; Bondhon TA; Hasan A; de Lourdes Pereira M; Rahmatullah M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057501
[TBL] [Abstract][Full Text] [Related]
19. [The neurology of COVID-19].
Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]